Skip to main content
Xvivo Perfusion logo

Xvivo Perfusion — Investor Relations & Filings

Ticker · XVIVO ISIN · SE0004840718 LEI · 549300G2464FYLS14B41 ST Manufacturing
Open in API
Filings indexed 286 across all filing types
Latest filing 2023-09-13 Capital/Financing Update
Country SE Sweden
Listing ST XVIVO

About Xvivo Perfusion

https://www.xvivogroup.com/

Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.

Recent filings

Filing Released Lang Actions
XVIVO avser att genomföra en riktad nyemission av aktier
Capital/Financing Update Classification · 100% confidence The document is a press release from XVIVO Perfusion AB announcing their intention to conduct a directed share issue (a private placement) to institutional investors. It details the purpose of the capital raise, the bookbuilding process, lock-up agreements, and legal disclaimers regarding the offering. This falls under the category of capital and financing updates.
2023-09-13 Swedish
XVIVO intends to carry out a directed share issue
Capital/Financing Update Classification · 100% confidence The document is a press release from XVIVO Perfusion AB announcing their intention to carry out a 'directed share issue' (a private placement of shares) to raise approximately SEK 440 million. It details the purpose of the capital raise, the accelerated bookbuilding process, and lock-up undertakings. This falls squarely under the definition of a 'Capital/Financing Update' (CAP), as it describes a specific fundraising activity and changes to the company's capital structure.
2023-09-13 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport januari-juni 2023' (Interim Report January-June 2023) for XVIVO Perfusion AB. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management analysis of business performance for the specified interim period. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2023
2023-07-13 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January-June 2023' and contains comprehensive financial statements, including income statements, cash flow data, key ratios, and management commentary for the specified period. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-07-13 English
XVIVO has decided to close the PrimECC® study for further patient inclusions – strategic opportunities will be evaluated
Regulatory Filings Classification · 95% confidence The document announces a strategic decision by XVIVO Perfusion AB to close patient recruitment for the PrimECC® study due to slow enrollment. It discusses the financial implications (SEK 15 million impairment) and the future evaluation of strategic opportunities. Crucially, the text ends with a statement: "*This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-07-12 19:16 CEST.*" This language, combined with the short length (4590 chars) and the presence of an attachment link, strongly indicates this is a formal regulatory disclosure intended to inform the market immediately about a material event, rather than a full report (like 10-K or IR) or a transcript (CT). Since it is a general regulatory announcement concerning business operations and strategy, and does not fit perfectly into specific categories like DIV, DIRS, or CAP, the most appropriate general regulatory filing category is Regulatory Filings (RNS).
2023-07-12 English
XVIVO har beslutat att avsluta ytterligare patientinkludering i studien av PrimECC® – strategiska möjligheter skall utvärderas
Report Publication Announcement Classification · 95% confidence The document is a press release dated July 12, 2023, announcing a strategic decision regarding a clinical study (PrimECC®). It details the discontinuation of patient enrollment due to slow recruitment and states that strategic opportunities will be evaluated. Crucially, the text ends with a section titled "Bifogade filer" (Attached files) which links to a PDF document detailing the announcement itself. The document length is short (4680 characters) and its primary function is to announce the publication of information and provide contact details, rather than being the full financial report (like 10-K or IR) or a specific regulatory filing like DIRS or DIV. This structure strongly suggests it is an announcement about a corporate event or filing, fitting the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it is a formal press release announcing a significant business decision and linking to the full details, RPA is the most precise fit, as it announces the publication of this news. If it were a mandatory regulatory filing not covered by other codes, RNS would apply, but RPA captures the nature of announcing the release of information best.
2023-07-12 Swedish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.